ThyssenKrupp Steel Angang New Steel to Build a Second Hot-Dip Coating Line in Dalian China

ThyssenKrupp Steel, Duisburg, and ANSC Angang New Steel Co, Anshan, are to build a second hot-dip coating line on the site of their joint venture TAGAL in Dalian in the north of China. The decision was taken by the two companies in April; the contracts with the equipment manufacturer CMI and consortium partners Siemens and Drever were signed today in Anshan.

Construction work commenced already. Costing 150 million US dollars, the new high-tech line "TAGAL II", owned equally by the joint venture partners, is scheduled to go into trial operation in early 2008. A total of 240 people will be employed there. Like its twin TAGAL I, which was commissioned in December 2003, the TAGAL II hot-dip coating line is designed for the production of around 400,000 metric tons of hot-dip coated steel sheet meeting the demanding surface requirements of the auto and appliance industries.

ThyssenKrupp Steel CEO Dr. Karl-Ulrich Köhler explains: "With the realization of TAGAL II we are expanding our strategic cooperation with our Chinese partner ANSC with a view to exploiting the market opportunities available in China together: By 2010 we expect demand to grow by 5.1 percent for automotive grades and 4.1 percent for grades for the appliance industry." The new line will be the second of its kind in northern China - the first being TAGAL I. The reasons for locating the joint venture in Dalian, a port with a population of 5.5 million, located 600 kilometers to the north east of Beijing and some 280 kilometers south of Anshan, were the site's advantages in terms of land, infrastructure and logistics: Located just ten kilometers from a container port, the site has ideal transport links. Designed in attractive colors, the 430-meter-long new building will cover a total area of 70,000 square meters.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.